These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 28710827)

  • 61. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluating the Reparative Potential of Secretome from Patient-Derived Induced Pluripotent Stem Cells during Ischemia-Reperfusion Injury in Human Cardiomyocytes.
    Rody E; Zwaig J; Derish I; Khan K; Kachurina N; Gendron N; Giannetti N; Schwertani A; Cecere R
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408608
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
    Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro platform of allogeneic stem cell-derived cardiomyocyte transplantation for cardiac conduction defects.
    Yoshida A; Lee JK; Tomoyama S; Miwa K; Shirakawa K; Hamanaka S; Yamaguchi T; Nakauchi H; Miyagawa S; Sawa Y; Komuro I; Sakata Y
    Europace; 2018 Sep; 20(9):1553-1560. PubMed ID: 29554331
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
    Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
    Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Generation of Functional Cardiomyocytes from the Synoviocytes of Patients with Rheumatoid Arthritis via Induced Pluripotent Stem Cells.
    Lee J; Jung SM; Ebert AD; Wu H; Diecke S; Kim Y; Yi H; Park SH; Ju JH
    Sci Rep; 2016 Sep; 6():32669. PubMed ID: 27609119
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
    Parveen S; Singh SP; Panicker MM; Gupta PK
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes.
    Correia C; Koshkin A; Duarte P; Hu D; Carido M; Sebastião MJ; Gomes-Alves P; Elliott DA; Domian IJ; Teixeira AP; Alves PM; Serra M
    Biotechnol Bioeng; 2018 Mar; 115(3):630-644. PubMed ID: 29178315
    [TBL] [Abstract][Full Text] [Related]  

  • 69. DNA damage-free iPS cells exhibit potential to yield competent cardiomyocytes.
    Miller JM; Mardhekar NM; Pretorius D; Krishnamurthy P; Rajasekaran NS; Zhang J; Kannappan R
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H801-H815. PubMed ID: 32057252
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative analysis of the cardiomyocyte differentiation potential of induced pluripotent stem cells reprogrammed from human atrial or ventricular fibroblasts.
    Wang L; Nguyen T; Rosa-Garrido M; Zhou Y; Cleveland DC; Zhang J
    Front Bioeng Biotechnol; 2023; 11():1108340. PubMed ID: 36845191
    [No Abstract]   [Full Text] [Related]  

  • 71. Electrophysiological Properties of Tetraploid Cardiomyocytes Derived from Murine Pluripotent Stem Cells Generated by Fusion of Adult Somatic Cells with Embryonic Stem Cells.
    Xu G; Fatima A; Breitbach M; Kuzmenkin A; Fügemann CJ; Ivanyuk D; Kim KP; Cantz T; Pfannkuche K; Schöler HR; Fleischmann BK; Hescheler J; Šarić T
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047520
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.
    Tachibana A; Santoso MR; Mahmoudi M; Shukla P; Wang L; Bennett M; Goldstone AB; Wang M; Fukushi M; Ebert AD; Woo YJ; Rulifson E; Yang PC
    Circ Res; 2017 Sep; 121(6):e22-e36. PubMed ID: 28743804
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.
    Broughton KM; Li J; Sarmah E; Warren CM; Lin YH; Henze MP; Sanchez-Freire V; Solaro RJ; Russell B
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H107-17. PubMed ID: 27199119
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
    Ting S; Chen A; Reuveny S; Oh S
    Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias.
    Gnecchi M; Stefanello M; Mura M
    Int J Cardiol; 2017 Jun; 237():49-52. PubMed ID: 28408106
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In Vivo Dynamic Metabolic Changes After Transplantation of Induced Pluripotent Stem Cells for Ischemic Injury.
    Wu S; Zhu Y; Liu H; Tang L; Du R; Shen Y; Feng J; Zhang K; Xu C; Zhang S; Chen Y; Song F; Zhu Y; Gu W; Liang P; Carrió I; Zhang H; Tian M
    J Nucl Med; 2016 Dec; 57(12):2012-2015. PubMed ID: 27561881
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Telomere Length Defines the Cardiomyocyte Differentiation Potency of Mouse Induced Pluripotent Stem Cells.
    Aguado T; Gutiérrez FJ; Aix E; Schneider RP; Giovinazzo G; Blasco MA; Flores I
    Stem Cells; 2017 Feb; 35(2):362-373. PubMed ID: 27612935
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes.
    Wu P; Deng G; Sai X; Guo H; Huang H; Zhu P
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33057659
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Discovery of Novel Small-Molecule Inducers of Heme Oxygenase-1 That Protect Human iPSC-Derived Cardiomyocytes from Oxidative Stress.
    Kirby RJ; Divlianska DB; Whig K; Bryan N; Morfa CJ; Koo A; Nguyen KH; Maloney P; Peddibhotla S; Sessions EH; Hershberger PM; Smith LH; Malany S
    J Pharmacol Exp Ther; 2018 Jan; 364(1):87-96. PubMed ID: 29101218
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stiff matrix induces switch to pure β-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes.
    Weber N; Schwanke K; Greten S; Wendland M; Iorga B; Fischer M; Geers-Knörr C; Hegermann J; Wrede C; Fiedler J; Kempf H; Franke A; Piep B; Pfanne A; Thum T; Martin U; Brenner B; Zweigerdt R; Kraft T
    Basic Res Cardiol; 2016 Nov; 111(6):68. PubMed ID: 27743117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.